Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company’s equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | Filing |
| 2024-01-22 4:31 pm Purchase | 13G | SOLID BIOSCIENCES INC SLDB | Artal International S.C.A. | 2,717,538 7.3% | 2,717,538 (New Position) | View |
| 2024-01-11 4:30 pm Purchase | 13G | GOSSAMER BIO INC GOSS | Artal International S.C.A. | 13,108,880 5.8% | 13,108,880 (New Position) | View |
| 2023-11-13 4:30 pm Purchase | 13G | KORRO BIO INC KRRO | Artal International S.C.A. | 418,605 5.2% | 418,605 (New Position) | View |
| 2023-09-01 4:12 pm Purchase | 13G | SILENCE THERAPEUTICS PLC SPONS SLN | Artal International S.C.A. | 7,500,000 6.8% | 7,500,000 (New Position) | View |
| 2023-06-12 4:30 pm Purchase | 13G | CARTESIAN THERAPEUTICS, INC. C RNAC | Artal International S.C.A. | 10,206,990 6.6% | 10,206,990 (New Position) | View |
| 2023-03-31 4:15 pm Purchase | 13G | HARPOON THERAPEUTICS INC HARP | Artal International S.C.A. | 2,347,437 6.1% | 2,347,437 (New Position) | View |
| 2023-02-13 5:18 pm Purchase | 13G | GLYCOMIMETICS INC GLYC | Artal International S.C.A. | 6,573,798 12.5% | 6,573,798 (New Position) | View |
| 2023-02-10 7:56 pm Purchase | 13G | MORPHIC HLDG INC MORF | Artal International S.C.A. | 2,150,000 5.6% | 564,951 (+35.64%) | View |
| 2023-02-10 7:53 pm Purchase | 13G | SQZ BIOTECHNOLOGIES CO COM SQZ | Artal International S.C.A. | 1,606,309 5.5% | 1,606,309 (New Position) | View |
| 2023-02-10 7:41 pm Sale | 13G | SYROS PHARMACEUTICALS INC SYRS | Artal International S.C.A. | 1,463,829 7.2% | -2,036,171 (-58.18%) | View |
| 2023-02-10 7:36 pm Sale | 13G | VIGIL NEUROSCIENCE INC VIGL | Artal International S.C.A. | 2,243,352 6.3% | -42,222 (-1.85%) | View |
| 2023-02-10 7:34 pm Sale | 13G | OMEGA ALPHA SPAC OMEG | Artal International S.C.A. | 0 0% | -750,000 (Position Closed) | View |
| 2023-02-10 7:33 pm Purchase | 13G | SCHOLAR ROCK HLDG CORP SRRK | Artal International S.C.A. | 10,555,278 19.8% | 230,236 (+2.23%) | View |
| 2023-02-10 7:31 pm Unchanged | 13G | NEXIMMUNE INC NEXI | Artal International S.C.A. | 1,200,000 4.6% | 0 (Unchanged) | View |
| 2023-02-10 7:28 pm Purchase | 13G | IGM BIOSCIENCES INC IGMS | Artal International S.C.A. | 2,450,000 8.4% | 950,000 (+63.33%) | View |
| 2023-02-10 7:28 pm Purchase | 13G | VERSARTIS INC ARAV | Artal International S.C.A. | 12,182,037 9.9% | 10,870,746 (+829.01%) | View |
| 2023-02-10 7:25 pm Sale | 13G | BELLUS HEALTH INC BLU | Artal International S.C.A. | 3,700,000 2.9% | -4,800,000 (-56.47%) | View |
| 2023-02-10 7:21 pm Unchanged | 13G | APTINYX INC APTX | Artal International S.C.A. | 6,116,493 9% | 0 (Unchanged) | View |
| 2023-02-10 7:21 pm Unchanged | 13G | AMBRX BIOPHARMA INC SPONSORED AMAM | Artal International S.C.A. | 15,066,043 5.6% | 0 (Unchanged) | View |
| 2023-02-10 7:15 pm Unchanged | 13G | ACHILLES THERAPEUTICS PLC ACHL | Artal International S.C.A. | 2,255,375 5.5% | 0 (Unchanged) | View |